142 related articles for article (PubMed ID: 38502494)
41. Increasing uptake of colorectal cancer screening in Korea: a population-based study.
Choi KS; Jun JK; Lee HY; Hahm MI; Oh JH; Park EC
BMC Public Health; 2010 May; 10():265. PubMed ID: 20492654
[TBL] [Abstract][Full Text] [Related]
42. Factors Associated with Colorectal Cancer Screening among Mississippi Adults: Findings from the Behavioral Risk Factor Surveillance System.
Zhang WQ; Tang SJ; Dobbs TE; Zhang L
South Med J; 2020 Jul; 113(7):360-365. PubMed ID: 32617599
[TBL] [Abstract][Full Text] [Related]
43. Patterns of colorectal cancer diagnosis among younger adults in a real-world, population-based cohort.
Abdel-Rahman O; Karachiwala H; Koski S
Future Oncol; 2022 Jan; 18(1):47-54. PubMed ID: 34763528
[TBL] [Abstract][Full Text] [Related]
44. The potential impact of the Affordable Care Act and Medicaid expansion on reducing colorectal cancer screening disparities in African American males.
Powell W; Frerichs L; Townsley R; Mayorga M; Richmond J; Corbie-Smith G; Wheeler S; Hassmiller Lich K
PLoS One; 2020; 15(1):e0226942. PubMed ID: 31978084
[TBL] [Abstract][Full Text] [Related]
45. The case for philanthropic investment to increase colorectal cancer screening rates: A novel paradigm to address a public health challenge.
Carmeli A; Dranikoff L; Kundu A; Ladabaum U
Cancer Med; 2020 Feb; 9(3):1220-1229. PubMed ID: 31808317
[TBL] [Abstract][Full Text] [Related]
46. Socioeconomic and physician supply determinants of racial disparities in colorectal cancer screening.
Soneji S; Armstrong K; Asch DA
J Oncol Pract; 2012 Sep; 8(5):e125-34. PubMed ID: 23277775
[TBL] [Abstract][Full Text] [Related]
47. Colorectal Cancer Screening in Switzerland: Cross-Sectional Trends (2007-2012) in Socioeconomic Disparities.
Fedewa SA; Cullati S; Bouchardy C; Welle I; Burton-Jeangros C; Manor O; Courvoisier DS; Guessous I
PLoS One; 2015; 10(7):e0131205. PubMed ID: 26147803
[TBL] [Abstract][Full Text] [Related]
48. Modelling cost-effective strategies for minimising socioeconomic inequalities in colorectal cancer screening outcomes in England.
Thomas C; Mandrik O; Whyte S
Prev Med; 2022 Sep; 162():107131. PubMed ID: 35803353
[TBL] [Abstract][Full Text] [Related]
49. Factors associated with participation in colorectal cancer screening in Korea: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV).
Myong JP; Shin JY; Kim SJ
Int J Colorectal Dis; 2012 Aug; 27(8):1061-9. PubMed ID: 22354136
[TBL] [Abstract][Full Text] [Related]
50. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.
Lew JB; St John DJB; Xu XM; Greuter MJE; Caruana M; Cenin DR; He E; Saville M; Grogan P; Coupé VMH; Canfell K
Lancet Public Health; 2017 Jul; 2(7):e331-e340. PubMed ID: 29253458
[TBL] [Abstract][Full Text] [Related]
51. [Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].
Chen HD; Li N; Ren JS; Shi JF; Zhang YM; Zou SM; Zheng ZX; Zhang K; Dai M
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):231-237. PubMed ID: 29973000
[No Abstract] [Full Text] [Related]
52. Effectiveness of an organized colorectal cancer screening program on increasing adherence in asymptomatic average-risk Canadians.
Charters TJ; Strumpf EC; Sewitch MJ
BMC Health Serv Res; 2013 Oct; 13():449. PubMed ID: 24168208
[TBL] [Abstract][Full Text] [Related]
53. Factors Associated with Participation in Stool Based Colorectal Screening in Brunei Darussalam.
Chong VH; Kadir L; Kamis Z; Kassim N; Khalil MAM; Tan J; Leong E; Ong SK; Chong CF
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2231-2236. PubMed ID: 32856849
[TBL] [Abstract][Full Text] [Related]
54. Socioeconomic Gradients in Prostate Cancer Incidence Among Canadian Males: A Trend Analysis From 1992 to 2010.
Hajizadeh M; Whelan A; Johnston GM; Urquhart R
Cancer Control; 2021; 28():10732748211055272. PubMed ID: 34889129
[TBL] [Abstract][Full Text] [Related]
55. Multilevel predictors of colorectal cancer screening use in California.
Shariff-Marco S; Breen N; Stinchcomb DG; Klabunde CN
Am J Manag Care; 2013; 19(3):205-16. PubMed ID: 23544762
[TBL] [Abstract][Full Text] [Related]
56. Use of Evidence-Based Interventions to Address Disparities in Colorectal Cancer Screening.
Joseph DA; Redwood D; DeGroff A; Butler EL
MMWR Suppl; 2016 Feb; 65(1):21-8. PubMed ID: 26915961
[TBL] [Abstract][Full Text] [Related]
57. Geographical variation and factors associated with colorectal cancer mortality in a universal health care system.
Torabi M; Green C; Nugent Z; Mahmud S; Demers A; Griffith J; Singh H
Can J Gastroenterol Hepatol; 2014 Apr; 28(4):191-7. PubMed ID: 24729992
[TBL] [Abstract][Full Text] [Related]
58. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
59. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives.
Hathway JM; Miller-Wilson LA; Jensen IS; Ozbay B; Regan C; Jena AB; Weinstein MC; Parks PD
J Med Econ; 2020 Jun; 23(6):581-592. PubMed ID: 32063100
[No Abstract] [Full Text] [Related]
60. Trends in colorectal cancer screening disparities in people aged 50-64 years, 2000-2005.
Trivers KF; Shaw KM; Sabatino SA; Shapiro JA; Coates RJ
Am J Prev Med; 2008 Sep; 35(3):185-93. PubMed ID: 18617355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
